Log on / register
Feedback | Support | My details
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
Betancourt BY, Marrero-Miragaya MA, Jiménez-López G, Valenzuela-Silva C, García-Iglesias E, Hernández-Bernal F, Debesa-García F, González-López T, Alvarez-Falcón L, López-Saura PA, Cuban National Network of Pharmacoepidemiology
BMC Clin Pharmacol 2005, 5:5
[Full text] [PubMed] [Related articles]


No citations for this article were found in PubMed Central.

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.